“Off-label”的搜索结果，显示 31-40 项，共有 564 项

1. 广告和赞助- 妙佑医疗国际

   美国食品和药品管理局批准的处方药; 与健康有关的消费品; 健身产品或服务; 医疗产品或器械; 药房（零售和在线药房，VIPPS 计划仅适用于在线药房 ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The present study is an open-label, randomized, controlled, two-arm multi-center study of the ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a single-arm, two-stage, phase II trial to assess the efficacy of futibatinib plus pembrolizumab in advanced hepatocellular carcinoma for patients ...

5. 皮肤科- 临床试验- 妙佑医疗国际

   The purpose of this study is to discover and validate DNA methylation-based markers that identify patients with metastatic melanoma based on the detection ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast or recurred after ...

7. 泌尿科- 临床试验- 妙佑医疗国际

   ... label phase for 3 months will be conducted. Final assessments for adverse effects will also be assessed at 9 months. Study to Evaluate 99mTc-MIP-1404 SPECT ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is a Phase III, randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This study evaluates CLR 131 in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/ ...

10. 广告与赞助政策- 妙佑医疗国际

    为了进一步履行使命，向公众提供可信赖的健康信息，我们设立了严格的广告和赞助接受标准。我们拒绝任何被认为有悖于我们使命的广告。我们的网站或刊物中出现的广告并不 ...